TP53 and breast cancer: Some of the top mutated genes identified in the Swedish BC cohort had similar prevalence in the Hungarian tumor samples (PIK3CA—26%, TTN—18%), but many of them were mutated more frequently (TP53—38%, KMT2C—32%, MUC17—29%, NEB—15%, GOLGB1—15%).